| ²é¿´: 885 | »Ø¸´: 8 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
xunyuÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
|
[½»Á÷]
¡¾2003 Marcel Dekker Ó¢ÎÄÔ°æ¡¿ÁÙ´²Ò©ÎïÑз¢ÖеÄÉúÎï±ê¼Ç
|
||
|
Biomarkers in Clinical Drug Development (Drugs and the Pharmaceutical Sciences: a Series of Textbooks and Monographs) (Hardcover) by John Bloom (Editor), Richard A. Dean (Editor) List Price: $199.95 Hardcover: 304 pages Publisher: Informa Healthcare (May 20, 2003) Language: English ISBN: 0824740262 Product Dimensions: 9.1 x 6.2 x 0.8 inches 1. Biomarkers in Clinical Drug Development efinitions and Disciplines2. The Clinical Laboratory and Collection of Biomarker Data 3. Using Imaging Biomarkers to Demonstrate Efficacy inClinical Trials: Trends and Challenges 4. Markers for Cardiac Repolarization and Risk Assessment 5. Development and Application of Interspecies Biomarkers in Nonclinical Safety Evaluations 6. Validation of Assays for the Bioanalysis of Novel Biomarkers ractical Recommendations for Clinical Investigation of New Drug Entities7. Validation of Biomarkers as Surrogates for Clinical Endpoints ................ ................ ÏÂÔØÁ´½Ó¼û¸½¼þÎı¾ Èç¹ûÄú¾õµÃ¸ÃÊé¶ÔÄúÓаïÖú£¬ÇëÄúÖ§³ÖһϠÄúµÄÖ§³ÖÊǶÔÂ¥Ö÷µÄÈϿɣ¬ÊÇÂÛ̳·¢Õ¹µÄ¶¯Á¦ ½ð±Ò²»×ãµÄ³æ×Ó¿ÉÒÔÕ¾ÄÚ·¢ËÍÏûÏ¢¸æÖª [ Last edited by xunyu on 2006-9-3 at 21:29 ] |
» ²ÂÄãϲ»¶
0703»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
Ò»Ö¾Ô¸Öпƴó070300»¯Ñ§£¬314·ÖÇóµ÷¼Á
ÒѾÓÐ7È˻ظ´
288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005
ÒѾÓÐ14È˻ظ´
070300»¯Ñ§279Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
086003µ÷¼ÁÇóÖú
ÒѾÓÐ12È˻ظ´
µ÷¼Á »¯Ñ§ 307
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸085502£¬267·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤289·Ö
ÒѾÓÐ22È˻ظ´
²ÄÁϹ¤³Ì322
ÒѾÓÐ19È˻ظ´

zhongmingyingzi
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 191.1
- É¢½ð: 200
- Ìû×Ó: 230
- ÔÚÏß: 10.2Сʱ
- ³æºÅ: 218365
- ×¢²á: 2006-03-13
- ÐÔ±ð: GG
- רҵ: ·ÖÎöÒÇÆ÷ÓëÊÔ¼Á

9Â¥2006-10-31 08:03:14
piaopry
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 512.6
- Ìû×Ó: 1126
- ÔÚÏß: 59.4Сʱ
- ³æºÅ: 174610
- ×¢²á: 2006-01-22
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
2Â¥2006-09-04 15:57:54













efinitions and Disciplines
ractical Recommendations for Clinical Investigation of New Drug Entities
»Ø¸´´ËÂ¥
